Gentamicin Sulphate Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 40mg/ml, 10mg/ml
Reference Brands: Garamycin (USA), Genoptic (USA) , Cidomycin (USA/EU)
Category:
Antibiotics
Gentamicin injection is used to treat serious bacterial infections in many different parts of the body. Gentamicin belongs to the class of medicines known as aminoglycoside antibiotics. It works by killing bacteria or preventing their growth.
Gentamicin Sulphate Injection is available in Injection
and strengths such as 40mg/ml, 10mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Gentamicin Sulphate Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Gentamicin Sulphate Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Gentamicin sulfate is a potent aminoglycoside antibiotic widely used for the treatment of serious bacterial infections caused by susceptible Gram-negative organisms. It is effective against a range of infections, including bacterial septicemia, meningitis, urinary tract infections, gastrointestinal infections, and soft tissue infections. The choice to use gentamicin is guided by patient age, presenting symptoms, clinical signs, and local antimicrobial resistance patterns to maximize the likelihood of successful therapy.
Gentamicin works by irreversibly binding to the 30S ribosomal subunit of bacteria, disrupting protein synthesis and leading to bacterial cell death. It is typically administered via intravenous or intramuscular routes, with careful dosing and monitoring to reduce the risk of nephrotoxicity and ototoxicity. Pharmacokinetic and pharmacodynamic considerations, including renal function and drug levels, are critical for safe and effective use.
In addition to its approved indications, gentamicin may be used off-label in specific clinical scenarios, under strict medical supervision. Its well-established efficacy, combined with a defined adverse event profile and clear administration guidelines, makes gentamicin a key agent in both nosocomial and community-acquired infections, offering healthcare providers a reliable tool for managing severe bacterial diseases.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing